TMPRSS2-ERG Fusion Prostate Cancer Prevalence Linked To PSA Density And Histologic Features In Multicenter US Prostate Biopsy Cohort
Jul 4th 2008Drug InformationProstate
ORLANDO, FL (UroToday.com) - In a certain proportion of prostate cancers, the prostate-specific androgen-regulated gene TMPRSS2 is fused with the gene for the transcription factor ERG. This gene fusion product may have prognostic significance in men with the CaP; however, the exact prevalence of the genetic abnormality is debated.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
